Anna Fabregas's Contact Details

Anna Fabregas's Company Details

MiMARK

Barcelona, Catalonia, Spain • 6 Employees
Research

In MiMARK, we care for women's health. We are specialized in the discovery, verification and validation of biomarkers to develop new solutions for gynecological patients.Abnormal vaginal bleeding affects 9M women in EU and US yearly. Diagnosis of endometrial cancer is mandatory since 10% of these women will suffer it. Current diagnosis is based on the pathological examination of an endometrial biopsy (pipelle biopsy), but this fails to diagnose 22% of patients, and provides an inaccurate diagnosis in 55% of cases. This failure is associated to the scarce cellularity of the sample. In those cases, invasive diagnosis using histeroscopy needs to be performed.Our solution is an in vitro diagnostic tool based on the determination of 5 protein biomarkers in uterine fluid samples to provide diagnosis to 100% of patients, rule out endometrial cancer with great specificity, and provide information on histological subtype of the tumor to guide surgical treatment